Both in Pharmaceuticals
Abbott Laboratories vs Pfizer
Over the past year ABT returned −24.2% and PFE returned +20.4%; their daily moves had a correlation of 0.20.
ABT −24.2% PFE +20.4%Growth of $1, one year, split-adjusted
| Metric | ABT | PFE |
|---|---|---|
| Price | $100.95 | $28.72 |
| Market cap | $174.68B | $163.69B |
| Today | −0.03% | 0.00% |
| 1 month | −10.2% | +2.7% |
| 6 months | −0.9% | +3.4% |
| Year to date | −19.4% | +15.3% |
| 1 year | −24.4% | +20.9% |
| Revenue growth (YoY) | +13.0% | +2.6% |
| Gross margin | 57.7% | 72.8% |
| Net margin | 7.4% | −1.6% |
| P/E (TTM) | 32.2× | 37.8× |
| Price / sales | 3.7× | 2.6× |
| Net cash | -$27.00B | -$51.49B |
| Dividend yield | 2.50% | 5.99% |
| Volatility (60d) | 29.9% | 18.6% |
| Short % of float | 1.2% | 3.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).